Your browser does not support iframes.
As we work tirelessly to challenge unmet patient needs, our focus is on:
Our scientists and researchers ensure optimal product formulation through analytical method development, stability testing and close management of bioequivalence and other clinical studies.
Teva’s R&D group has an exceptional track record in translating early drug opportunities into clinically-proven drug candidates. Our research and manufacturing facilities are fully equipped to support both GLP development and cGMP manufacture.
In therapeutic delivery, our capabilities have expanded beyond tablets, capsules, liquids, ointments and creams to a broad range of dosage forms and delivery systems. These include sterile devices, long acting release injectables, transdermal patches and films, and nasal suspensions. Our R&D group continues to develop an array of special delivery technologies ranging from extended-release to drug device combinations.